Skip to main content
Log in

Effects of Selol 5% supplementation on tissue antioxidant enzyme levels and peroxidation marker in healthy mice

  • Original article
  • Published:
Pharmacological Reports Aims and scope Submit manuscript

Abstract

Background

Selenium (Se) is an essential micronutrient for animals and humans used in the prevention or treatment of cancer. Selol is a mixture of selenitetriglycerides, containing Se(IV). It does not exhibit mutagenic activity and is less toxic than inorganic sodium selenite containing Se(IV). The antioxidant properties of the Selol were demonstrated using the blood of healthy animals. The aim of the study was to evaluate Selol as a Se supplement by determining the effect of its administration on the Se level and the antioxidant status in the tissues.

Methods

We examined the effect of long-term (28-day) Selol 5% supplementation on the activity of antioxidant enzymes, including the main selenoenzymes in healthy mice organs, such as liver, brain, lungs, and testis. Enzyme activities of the tissue homogenates and the concentration of malondialdehyde (MDA) as a biomarker of oxidative stress were measured using spectrophotometric methods. The selenium concentrations in the tissues were determined by inductively coupled plasma mass spectrometer (ICP-MS) as well.

Results

A significant increase in glutathione peroxidase, thioredoxin reductase, and glutathione S-transferase activity as well as the MDA concentration was observed in most of the studied tissues during the Selol 5% supplementation.

Conclusions

Long-term supplementation with the new Se(IV) compound — Selol 5% significantly affects the activity of antioxidant enzymes and the redox state in healthy mice organs. In the healthy population Selol 5% seems to be a promising new antioxidant compound.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rayman M.P.. Selenium and human health. Lancet 2012;379(9822):1256–68.

    Article  CAS  PubMed  Google Scholar 

  2. Dominiak A, Wilkaniec A, Wroczynski P, Adamczyk A. Selenium in the therapy of neurological diseases. Where is it going? Curr Neuropharmacol 2016;14(3):282–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Gromer S, Urig S, Becker K. The thioredoxin system-from science to clinic. Med Res Rev 2004;24(1):40–89.

    Article  CAS  PubMed  Google Scholar 

  4. Brigelius-Flohe R. Tissue-specific functions of individual glutathione peroxidases. Free Radic Biol Med 1999;27(9–10):951–65.

    Article  CAS  PubMed  Google Scholar 

  5. Lanfear J, Fleming J, Wu L, Webster G, Harrison PR. The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium? Carcinogenesis 1994;15(7):1387–92.

    Article  CAS  PubMed  Google Scholar 

  6. Drake EN. Cancer chemoprevention: selenium as a prooxidant, not an antioxidant. Med Hypotheses 2006;67(2):318–22.

    Article  CAS  PubMed  Google Scholar 

  7. Soriano-Garcia M. Organoselenium compounds as potential therapeutic and chemopreventive agents: a review. Curr Med Chem 2004;11(12):1657–69.

    Article  CAS  PubMed  Google Scholar 

  8. Jastrzebski Z, Czyzewska-Szafran H, Fijatek Z, Suchocki P, Fitak BA. Toxicity studies of a new selenium compound, Selol, in rats. Drugs Exp Clin Res 1995;21(6):217–20.

    CAS  PubMed  Google Scholar 

  9. Rahden-Staron I, Suchocki P, Czeczot H. Evaluation of mutagenic activity of the organo-selenium compound Selol by use of the Salmonella typhimurium mutagenicity assay. Mutat Res 2010;699(1–2):44–6.

    Article  CAS  PubMed  Google Scholar 

  10. Wendel A. Glutathione peroxidase. Methods Enzymol 1981;77:325–33.

    Article  CAS  PubMed  Google Scholar 

  11. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70(1):158–69.

    CAS  PubMed  Google Scholar 

  12. Sochacka M, Giebultowicz J, Remiszewska M, Suchocki P, Wroczynski P. Effects of Selol 5% supplementation on the activity or concentration of antioxidants and malondialdehyde level in the blood of healthy mice. Pharmacol Rep 2014;66(2):301–10.

    Article  CAS  PubMed  Google Scholar 

  13. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249(25):7130–9.

    CAS  PubMed  Google Scholar 

  14. Mustacich D, Powis G. Thioredoxin reductase. Biochem J 2000;346:1–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Hill KE, McCollum GW, Boeglin ME, Burk RF. Thioredoxin reductase activity is decreased by selenium deficiency. Biochem Biophys Res Commun 1997;234(2):293–5.

    Article  CAS  PubMed  Google Scholar 

  16. Gromer S, Johansson L, Bauer H, Arscott LD, Rauch S, Ballou DP, et al. Active sites of thioredoxin reductases: why selenoproteins? Proc Natl Acad Sci USA 2003;100(22):12618–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Nixon DE, Moyer TP, Burritt MF. The determination of selenium in serum and urine by inductively coupled plasma mass spectrometry: comparison with Zeeman graphite furnace atomic absorption spectrometry. Spectrochim Acta B 1999;54(6):931–42.

    Article  Google Scholar 

  18. Brenneisen P, Steinbrenner H, Sies H. Selenium, oxidative stress, and health aspects. Mol Aspects Med 2005;26(4–5):256–67.

    Article  CAS  PubMed  Google Scholar 

  19. Ganther HE. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 1999;20(9):1657–66.

    Article  CAS  PubMed  Google Scholar 

  20. Dominiak A, Wilkaniec A, Jesko H, Czapski GA, Lenkiewicz AM, Kurek E, et al. Selol, an organic selenium donor, prevents lipopolysaccharide-induced oxidative stress and inflammatory reaction in the rat brain. Neurochem Int 2017;108:66–7.

    Article  CAS  PubMed  Google Scholar 

  21. Corcoran NM, Najdovska M, Costello AJ. Inorganic selenium retards progression of experimental hormone refractory prostate cancer. J Urol 2004;171(2, Part 1):907–10.

    Article  CAS  PubMed  Google Scholar 

  22. Crespo AM, Neve J, Pinto RE. Plasma and liver selenium levels in the rat during supplementation with 0.5, 2, 6, and 15 ppm selenium in drinking water. Biol Trace Elem Res 1993;38(2):139–47.

    Article  CAS  PubMed  Google Scholar 

  23. Thompson KG, Fraser AJ, Harrop BM, Kirk JA, Bullians J, Cordes DO. Glutathione peroxidase activity and selenium concentration in bovine blood and liver as indicators of dietary selenium intake. N Z Vet J 1981;29(1–2):3–6.

    Article  CAS  PubMed  Google Scholar 

  24. Weiss SL, Sunde RA. Selenium regulation of classical glutathione peroxidase expression requires the 3′ untranslated region in Chinese hamster ovary cells. J Nutr 1997;127(7):1304–10.

    Article  CAS  PubMed  Google Scholar 

  25. Hadley KB, Sunde RA. Selenium regulation of thioredoxin reductase activity and mRNA levels in rat liver. J Nutr Biochem 2001;12(12):693–702.

    Article  CAS  PubMed  Google Scholar 

  26. Chen J, Berry MJ. Selenium and selenoproteins in the brain and brain diseases. J Neurochem 2003;86(1):1–12.

    Article  CAS  PubMed  Google Scholar 

  27. Sun Y, Butler JA, Whanger PD. Glutathione peroxidase activity and selenoprotein W levels in different brain regions of selenium-depleted rats (1). J Nutr Biochem 2001;12(2):88–94.

    Article  CAS  PubMed  Google Scholar 

  28. Whanger PD. Selenium and the brain: a review. Nutr Neurosci 2001;4(2):81–97.

    Article  CAS  PubMed  Google Scholar 

  29. Rahman I, MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med 2000;28(9):1405–20.

    Article  CAS  PubMed  Google Scholar 

  30. Berggren MM, Mangin JF, Gasdaka JR, Powis G. Effect of selenium on rat thioredoxin reductase activity: increase by supranutritional selenium and decrease by selenium deficiency. Biochem Pharmacol 1999;57(2):187–93.

    Article  CAS  PubMed  Google Scholar 

  31. Suchocki P, Misiewicz-Krzeminska I, Skupinska K, Niedzwiecka K, Lubelska K, Fijalek Z, et al. Selenitetriglicerydes affect CYP1A1 and QR activity by involvement of reactive oxygen species and Nrf2 transcription factor. Pharmacolo Rep 2010;62(2):352–61.

    Article  CAS  Google Scholar 

  32. Mehlert A, Diplock AT. The glutathione S-transferases in selenium and vitamin E deficiency. Biochem J 1985;227(3):823–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. El-Demerdash FM. Effects of selenium and mercury on the enzymatic activities and lipid peroxidation in brain, liver, and blood of rats. J Environ Sci Health B 2001;36(4):489–99.

    Article  CAS  PubMed  Google Scholar 

  34. Kaur P, Bansal MP. Effect of selenium-induced oxidative stress on the cell kinetics in testis and reproductive ability of male mice. Nutrition 2005;21(3):351–7.

    Article  CAS  PubMed  Google Scholar 

  35. Sanchez-Valle V, Chavez-Tapia NC, Uribe M, Mendez-Sanchez N. Role of oxidative stress and molecular changes in liver fibrosis: a review. Curr Med Chem 2012;19(28):4850–60.

    Article  CAS  PubMed  Google Scholar 

  36. Flis A, Suchocki P, Krolikowska MA, Suchocka Z, Remiszewska M, Sliwka L, et al. Selenitetriglycerides-redox-active agents. Pharmacol Rep 2015;67(1):1–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Małgorzata Sochacka.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sochacka, M., Giebułtowicz, J., Remiszewska, M. et al. Effects of Selol 5% supplementation on tissue antioxidant enzyme levels and peroxidation marker in healthy mice. Pharmacol. Rep 70, 1073–1078 (2018). https://doi.org/10.1016/j.pharep.2018.06.003

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.pharep.2018.06.003

Keywords

Navigation